MEDICLIN Aktiengesellschaft (ETR:MED)
Germany
· Delayed Price · Currency is EUR ETR:MED Statistics
Total Valuation
ETR:MED has a market cap or net worth of EUR 142.50 million. The enterprise value is 494.84 million.
| Market Cap | 142.50M |
| Enterprise Value | 494.84M |
Important Dates
The next estimated earnings date is Thursday, July 31, 2025.
| Earnings Date | Jul 31, 2025 |
| Ex-Dividend Date | Jun 5, 2025 |
Share Statistics
ETR:MED has 47.50 million shares outstanding.
| Current Share Class | 47.50M |
| Shares Outstanding | 47.50M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | 37.25% |
| Float | 11.44M |
Valuation Ratios
The trailing PE ratio is 5.49 and the forward PE ratio is 4.62.
| PE Ratio | 5.49 |
| Forward PE | 4.62 |
| PS Ratio | 0.19 |
| PB Ratio | 0.64 |
| P/TBV Ratio | 0.71 |
| P/FCF Ratio | 3.49 |
| P/OCF Ratio | 1.77 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 4.83, with an EV/FCF ratio of 12.11.
| EV / Earnings | 18.98 |
| EV / Sales | 0.65 |
| EV / EBITDA | 4.83 |
| EV / EBIT | 9.63 |
| EV / FCF | 12.11 |
Financial Position
The company has a current ratio of 1.81, with a Debt / Equity ratio of 2.04.
| Current Ratio | 1.81 |
| Quick Ratio | 1.73 |
| Debt / Equity | 2.04 |
| Debt / EBITDA | 4.46 |
| Debt / FCF | 11.19 |
| Interest Coverage | 2.33 |
Financial Efficiency
Return on equity (ROE) is 12.52% and return on invested capital (ROIC) is 4.76%.
| Return on Equity (ROE) | 12.52% |
| Return on Assets (ROA) | 3.57% |
| Return on Invested Capital (ROIC) | 4.76% |
| Return on Capital Employed (ROCE) | 7.01% |
| Revenue Per Employee | 104,536 |
| Profits Per Employee | 3,576 |
| Employee Count | 10,472 |
| Asset Turnover | 0.85 |
| Inventory Turnover | 80.95 |
Taxes
In the past 12 months, ETR:MED has paid 7.09 million in taxes.
| Income Tax | 7.09M |
| Effective Tax Rate | 21.26% |
Stock Price Statistics
The stock price has increased by +20.97% in the last 52 weeks. The beta is 0.21, so ETR:MED's price volatility has been lower than the market average.
| Beta (5Y) | 0.21 |
| 52-Week Price Change | +20.97% |
| 50-Day Moving Average | 2.96 |
| 200-Day Moving Average | 2.72 |
| Relative Strength Index (RSI) | 49.52 |
| Average Volume (20 Days) | 8,455 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, ETR:MED had revenue of EUR 762.28 million and earned 26.08 million in profits. Earnings per share was 0.55.
| Revenue | 762.28M |
| Gross Profit | 165.08M |
| Operating Income | 51.39M |
| Pretax Income | 33.34M |
| Net Income | 26.08M |
| EBITDA | 73.58M |
| EBIT | 51.39M |
| Earnings Per Share (EPS) | 0.55 |
Balance Sheet
The company has 105.03 million in cash and 457.06 million in debt, giving a net cash position of -352.03 million or -7.41 per share.
| Cash & Cash Equivalents | 105.03M |
| Total Debt | 457.06M |
| Net Cash | -352.03M |
| Net Cash Per Share | -7.41 |
| Equity (Book Value) | 223.81M |
| Book Value Per Share | 4.71 |
| Working Capital | 132.72M |
Cash Flow
In the last 12 months, operating cash flow was 80.51 million and capital expenditures -39.66 million, giving a free cash flow of 40.85 million.
| Operating Cash Flow | 80.51M |
| Capital Expenditures | -39.66M |
| Free Cash Flow | 40.85M |
| FCF Per Share | 0.86 |
Margins
Gross margin is 21.66%, with operating and profit margins of 6.74% and 3.42%.
| Gross Margin | 21.66% |
| Operating Margin | 6.74% |
| Pretax Margin | 4.37% |
| Profit Margin | 3.42% |
| EBITDA Margin | 9.65% |
| EBIT Margin | 6.74% |
| FCF Margin | 5.36% |
Dividends & Yields
This stock pays an annual dividend of 0.04, which amounts to a dividend yield of 1.33%.
| Dividend Per Share | 0.04 |
| Dividend Yield | 1.33% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | 1.29% |
| Earnings Yield | 18.30% |
| FCF Yield | 28.67% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
ETR:MED has an Altman Z-Score of 1.4 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.4 |
| Piotroski F-Score | 6 |